CN113846060A - Application of nano material in promoting differentiation of embryonic stem cells to neural precursor cells - Google Patents
Application of nano material in promoting differentiation of embryonic stem cells to neural precursor cells Download PDFInfo
- Publication number
- CN113846060A CN113846060A CN202111271780.XA CN202111271780A CN113846060A CN 113846060 A CN113846060 A CN 113846060A CN 202111271780 A CN202111271780 A CN 202111271780A CN 113846060 A CN113846060 A CN 113846060A
- Authority
- CN
- China
- Prior art keywords
- nano
- differentiation
- double hydroxide
- layered double
- embryonic stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000004069 differentiation Effects 0.000 title claims abstract description 69
- 210000001671 embryonic stem cell Anatomy 0.000 title claims abstract description 53
- 210000004027 cell Anatomy 0.000 title claims abstract description 33
- 230000001537 neural effect Effects 0.000 title claims abstract description 25
- 239000002243 precursor Substances 0.000 title claims abstract description 21
- 230000001737 promoting effect Effects 0.000 title claims abstract description 15
- 239000002086 nanomaterial Substances 0.000 title abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 15
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 5
- 150000001768 cations Chemical class 0.000 claims description 12
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 8
- 150000001450 anions Chemical class 0.000 claims description 4
- 239000010410 layer Substances 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 2
- 239000011229 interlayer Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 16
- 230000014509 gene expression Effects 0.000 abstract description 14
- 102000004169 proteins and genes Human genes 0.000 abstract description 12
- 238000001514 detection method Methods 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000001939 inductive effect Effects 0.000 abstract description 2
- 210000000653 nervous system Anatomy 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 abstract description 2
- 239000002771 cell marker Substances 0.000 abstract 1
- 238000000975 co-precipitation Methods 0.000 abstract 1
- 230000003013 cytotoxicity Effects 0.000 abstract 1
- 231100000135 cytotoxicity Toxicity 0.000 abstract 1
- 239000000463 material Substances 0.000 description 30
- 102000007354 PAX6 Transcription Factor Human genes 0.000 description 15
- 101150081664 PAX6 gene Proteins 0.000 description 15
- 102000000905 Cadherin Human genes 0.000 description 14
- 108050007957 Cadherin Proteins 0.000 description 14
- 108050000637 N-cadherin Proteins 0.000 description 14
- 239000003550 marker Substances 0.000 description 12
- 101100310657 Mus musculus Sox1 gene Proteins 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 238000011529 RT qPCR Methods 0.000 description 8
- 238000007792 addition Methods 0.000 description 8
- 101150009249 MAP2 gene Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 3
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 108010008125 Tenascin Proteins 0.000 description 2
- 102100038126 Tenascin Human genes 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 210000005064 dopaminergic neuron Anatomy 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000002161 motor neuron Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100400452 Caenorhabditis elegans map-2 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 1
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 1
- 239000006147 Glasgow's Minimal Essential Medium Substances 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004703 blastocyst inner cell mass Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- MHKWSJBPFXBFMX-UHFFFAOYSA-N iron magnesium Chemical compound [Mg].[Fe] MHKWSJBPFXBFMX-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- -1 magnesium-aluminum-magnesium-iron Chemical compound 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- 210000000535 oligodendrocyte precursor cell Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000000730 protein immunoprecipitation Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000001132 ultrasonic dispersion Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/16—Magnesium; Mg chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/22—Zinc; Zn chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to an application of a nano material in promoting differentiation of embryonic stem cells to neural precursor cells. The method firstly adopts a coprecipitation method to synthesize the nano-layered double hydroxide consisting of different metal ions at normal temperature, a cell survival rate detection experiment proves that the nano-layered double hydroxide has low cytotoxicity on the embryonic stem cells, and by detecting the expression of a neural precursor cell marker gene or protein, the nano-layered double hydroxide added into a system for inducing the embryonic stem cells to differentiate into the neural precursor cells is found to remarkably promote the differentiation, and the adding time and concentration of the nano-layered double hydroxide are further optimized, so that the induced differentiation effect is remarkably improved. The invention provides a new strategy for promoting the differentiation of embryonic stem cells to neural precursor cells and creates conditions for treating related diseases of the nervous system.
Description
Technical Field
The invention relates to induced differentiation of stem cells, in particular to application of a nano material in promoting differentiation of embryonic stem cells to neural precursor cells.
Background
Stem cell transplantation brings new hopes for the treatment of central nervous system diseases, and the regulation and mechanism analysis of stem cell fate are leading research fronts and hot spots in the field. Embryonic Stem Cells (ESCs) with totipotency of differentiation can be differentiated into specific nerve cell types under a proper external signal induction condition, including Neural Precursor Cells (NPCs), dopaminergic neurons, motor neurons, oligodendrocyte precursor cells and the like, and provide a series of solutions for treatment after nerve injury. Among them, NPCs are not only capable of self-renewal and differentiation into all types of nerve cells, but also capable of migration and integration into damaged sites of the central nervous system, and thus are ideal therapeutic means for nervous system-related diseases. Therefore, finding a new method for regulating differentiation of ESCs into NPCs and revealing the mechanism of ESCs have important scientific significance.
The prior art discloses some differentiation methods of ESCs to NPCs, for example, patent document CN107254442A discloses a method for differentiating neural precursor cells from embryonic stem cells, which is characterized in that the embryonic stem cells are cultured in vitro in the form of colonies, and peripheral cells are more easily differentiated due to the compact cells in the middle of the colonies and strong interaction among the cells; journal paper (plum, chenhong wei, huixing, etc. directed differentiation of human embryonic stem cells into neural precursor cells [ J ] zoology research, 2007,28 (3)) discloses inducing the directional differentiation of human embryonic stem cells cultured in a homologous feeder layer under a serum-free condition by adopting a single-layer adherent differentiation method to obtain a high proportion of neural precursor cells; journal papers (huzhixing, gunny, liangming. hepatocyte growth factor promotes differentiation of human embryonic stem cells into neural precursor cells [ J ]. journal of chinese pathophysiology, 2010,26(4) ], disclose that a serum-free neural differentiation system containing Hepatocyte Growth Factor (HGF) and G5 can effectively induce neural differentiation of hESCs.
Since the size of the nano material is similar to that of biological molecules, the nano material is easy to interact with DNA or protein in organs, tissues or cells, and the research of regulating and controlling the fate of ESCs through the physicochemical properties of the nano material is an important research direction in the field. In recent years, more and more studies have been conducted to control the neural differentiation process of ESCs using nanomaterials with stable biochemical properties. The nanomaterial can induce differentiation of ESCs into motor neurons, dopaminergic neurons, and glial cells. However, no report related to the regulation of differentiation from ESCs to NPCs by nanomaterials is available at present.
Disclosure of Invention
The invention aims to provide a new application of nano-layered double hydroxide aiming at the defects in the prior art.
It is still another object of the present invention to provide a method for promoting differentiation of embryonic stem cells into neural precursor cells.
In order to achieve the first purpose, the invention adopts the technical scheme that:
the application of the nano layered double hydroxide in promoting the differentiation of embryonic stem cells to neural precursor cells.
As a preferred embodiment of the invention, the nano-layered double hydroxide has divalent metal cations selected from Mg2+、Zn2+And Ca2+。
As another preferred example of the present invention, the nano-layered double hydroxide has a trivalent metal cation selected from Al3+And Fe3+。
As another preferred example of the present invention, the nano-layered double hydroxide has an interlayer anion selected from Cl-、NO3 -And SO4 2-。
In another preferred embodiment of the present invention, the molar ratio of the divalent metal ions to the trivalent metal ions of the nano-layered double hydroxide is (0.1-5): 1.
As another preferable example of the present invention, the nano-layered double hydroxide has a general formula of [ M2+ (1-x)M3+ x(OH)2]x+[An-]x/n·zH2O, wherein M2+Is a divalent metal cation, M3+Is a trivalent metal cation, An-Is an anion with the valence of n between layers, x is the molar ratio of trivalent cations to all cations, and z is the number of crystal water between each nano-layered double hydroxide molecule.
In order to achieve the second object, the invention adopts the technical scheme that:
a method for promoting differentiation of embryonic stem cells into neural precursor cells comprises the step of adding a nano layered double hydroxide into a system for differentiation of embryonic stem cells into neural precursor cells.
As a preferred example of the present invention, the nano-layered double hydroxide is added on days 3 to 5 of the induced differentiation culture.
As another preferable example of the present invention, the concentration of the nano-layered double hydroxide in the differentiation system is 1 to 40. mu.g/mL.
More preferably, the concentration of the nano-layered double hydroxide in the differentiation system is 10 μ g/mL.
The invention has the advantages that:
1. the method specifically induces the differentiation of the ESCs to the NPCs by adopting the nano-layered double hydroxide for the first time, defines the new function of the nano-layered double hydroxide in the regulation and control of the fate of the ESCs, and provides a strategy for optimizing a differentiation system of the ESCs to the NPCs.
2. According to the invention, the nanolayered double hydroxide and the ESCs are co-cultured, materials are added into a differentiation system of the ESCs according to concentration gradients and different time windows respectively, and the expression levels of the corresponding NPCs marker genes and proteins are detected, so that the appropriate concentration and the key time window for promoting the NPCs differentiation by the nanolayered double hydroxide are found, and the effect of induced differentiation is obviously improved.
3. The invention adopts the immunoblotting method to determine the effect of the nano-layered material in promoting the differentiation of the ESCs to the NPCs, and provides a new strategy for optimizing the neural differentiation system of the ESCs.
Drawings
FIG. 1: characterization of the nanomaterial LDH and effect on the cell proliferative capacity of mESCs. (A) TEM detects the structure of two LDHs; (B) detecting the Zeta potential of the surface of the material; (C) CCK8 measures cell viability at different concentrations of LDH-treated mESCs 24h and 48 h.
FIG. 2: qPCR detects the influence on the expression level of NPCs marker genes Sox1, Pax6, N-cadherin and Map2 after MgFe-LDH and MgAl-LDH materials are added in the differentiation of ESCs to NPCs.
FIG. 3: screening the optimal time window for MgFe-LDH materials to promote the differentiation of mESCs to NPCs. (A) The qPCR detects the expression level of NPCs marker genes Sox1, Pax6, N-cadherin and Map2 after MgFe-LDH is added on the 1 st to 5 th days during the differentiation of ESCs to NPCs; (B) immunofluorescence detects the fluorescence signals of the marker proteins Sox1, Pax6 and N-cadherin.
FIG. 4: and (3) screening the optimal concentration of the MgFe-LDH material for promoting differentiation of ESCs to NPC. (A) qPCR detects the expression level of NPCs marker gene after materials with different concentrations are added in the 5 th day of the differentiation process of NPCs; (B) detecting the expression of the NPCs marker protein by Western blot; (C) and (5) carrying out quantitative statistics on the Western blot.
Detailed Description
The following detailed description of the present invention will be made with reference to the accompanying drawings.
Mouse Embryonic Stem Cells (ESCs) are derived from a blastocyst inner cell mass, are pluripotent stem cells with self-renewal and multidirectional differentiation potential, are induced into Neural Precursor Cells (NPCs) and have high survival rate and plasticity in nerve transplantation, and can reduce the risk of teratoma formation. Therefore, a complete set of induction culture system for NPCs differentiation can provide a foundation for future clinical cell transplantation treatment.
In the following examples, DMEM, fetal bovine serum, GMEM, serum analogs (KOSR), non-essential amino acids, glutamine and diabody, which are used as essential components of cell culture media for maintaining normal cell growth, are commercially available products from Gibco, USA, and other non-self-made reagents and materials are commercially available.
Example 1
1. Two LDH materials with different metal elements are successfully prepared, and characterization and biocompatibility detection are carried out on the LDH materials
(1) Preparation of magnesium-aluminum-magnesium-iron LDH (layered double hydroxide) nano material
Step one, preparing 60mL salt solution by using 6mmol of magnesium nitrate and 2mmol of aluminum nitrate or 2mmol of ferric nitrate, wherein Mg2+With Al3+Or Fe3+The molar ratio therebetween was 3: 1.
Step two, CO removal2ddH of2A0.016M NaOH solution (40 mL) was prepared using O (double distilled water) as a solvent.
Step three, continuously administering N2Meanwhile, the mixed salt prepared in the step one60mL of the solution was added to 40mL of 0.016M NaOH solution obtained in step two under vigorous stirring (400 rpm) to obtain a first suspension.
And step four, transferring the first suspension to a hydrothermal synthesis kettle, and heating for 16h at 100 ℃ to obtain a second suspension.
Step five, centrifuging 20000g for 15min to collect the product and removing CO2After washing twice with the double distilled water, the colloidal material was stored in a refrigerator at 4 ℃.
And step six, drying the second suspension in a vacuum drying oven to obtain magnesium-aluminum LDH (MgAl-LDH) or magnesium-iron LDH (MgFe-LDH).
And (3) detecting the structure of the material by using a Transmission Electron Microscope (TEM), preparing two LDHs into a suspension of 0.1mg/mL, and ultrasonically dispersing for 30min to enable the sample to be a uniform solution, wherein FIG. 1A is a transmission electron microscope morphology image of the two LDHs. As shown in FIG. 1A, MgAl-LDH and MgFe-LDH both have hexagonal layered structures, are distributed uniformly, and have particle sizes of about 80-120nm (FIG. 1A).
(2) Surface potential determination of nano LDH
The two LDHs are prepared into 1mg/mL suspension, the sample is made into a uniform solution by ultrasonic dispersion for 30min, particle size detection and surface Zeta potential detection are carried out by using a particle size analyzer, and the detection result is shown in figure 1B. FIG. 1B is the surface potential of both LDHs at a concentration of 0.5mg/mL, indicating that the surface potential of MgAl-LDH is about 24.4mV and the surface potential of MgFe-LDH is about 13.4mV, indicating that both LDH materials in this example have Zeta potentials that are positive, are stable, and facilitate contact with negatively charged cell membranes and entry into the cells.
(3) Cell viability assay for ESCs following Nano-LDH treatment
Step one, culturing the mouse embryonic stem cell ESCs. ESCs were plated on 96-well plates at 8000 plates/well in medium at 37 ℃ with 5% CO2Culturing for 24h under the condition for subsequent treatment of the medicine or the material. The ESCs culture medium comprises the following raw materials: DMEM; FBS; (ii) glutamine; double antibody. In this experiment, the incubation time was 24 h.
And step two, preparing solutions with five concentrations, wherein the concentrations are 2.5 mu g/mL, 5 mu g/mL, 10 mu g/mL, 20 mu g/mL and 40 mu g/mL in sequence.
And step three, discarding the supernatant of the ESCs cells cultured in the step one, adding LDH solutions with different concentrations prepared in the step two into each hole, culturing for 24 hours, adding 10 mu L of CCK-8 solution with the concentration of 5mg/mL into each hole, placing for 2 hours in a dark place, vibrating for 10s in the dark place, and measuring the OD (optical density) value at the position of 455nm wavelength by using a microplate reader, wherein the detection result is shown in figure 1C. The cell proliferation capacity of the mESCs is detected after the two LDH materials are respectively treated for 7 days according to concentration gradients of 2.5 mu g/mL, 5 mu g/mL, 10 mu g/mL, 20 mu g/mL and 40 mu g/mL, and the result shows that the cell proliferation capacity is not influenced.
2. MgFe-LDH can better promote mESCs to differentiate into NPCs than MgAl-LDH material
Step one, culturing the mouse embryonic stem cell ESCs. ESCs were plated on 6cm suspension culture dishes at a plating density of 2X 105Cell/well, cultured in Neural Precursor Cells (NPCs) medium at 37 deg.C in 5% CO2Performing differentiation culture for 1-5 days under the condition for subsequent treatment of medicine or material. The NPCs culture medium comprises the following raw materials: GMEM; 8% KOSR; 1% glutamine; 1% double antibody. The media components are commercially available from Gibco.
And step two, respectively preparing MgFe-LDH and MgAl-LDH solutions with the concentrations of 2.5 mug/mL, 5 mug/mL and 10 mug/mL, adding two LDH materials with different concentrations for treating for 48 hours on the 5 th day of differentiation from the ESCs to the NPCs, collecting cells at each time point, cracking by Trizol, extracting total RNA, carrying out reverse transcription by using a cDNA reverse transcription kit to obtain cDNA, and detecting expression of NOC differentiation related genes by real-time quantitative PCR (Sox1, Pax6, N-cadherin and Map 2).
And step three, finding the NPCs marker gene expression by using qPCR detection, and finding that the NPCs treated by MgFe-LDH under various concentration conditions can better promote the expression of NPCs marker genes Sox1, Pax6, N-cadherin and Map2 compared with a control group and an MgAl-LDH group by using the result of figure 2, so that the material is adopted in subsequent experiments.
3. Optimum time point for MgFe-LDH nano material to promote differentiation of ESCs to NPCs
Step one, inoculating ESCs on a 6cm suspension culture dish, and paving the dish at a density of 2 multiplied by 105And/well, considering that the differentiation of NPCs reaches higher maturity substantially at day 5, we added 10. mu.g/mL of MgFe-LDH material to the differentiation of ESCs to NPCs at days 1-5, changed the culture broth every 3 days and harvested the cells to examine the differentiation efficiency of NPCs at day 7 by qPCR, respectively, FIG. 3A is the effect on the differentiation marker genes Sox1, Pax6, N-cadherin and Map2 of NPCs after the addition of MgFe-LDH material at days 1, 2, 3, 4 and 5, respectively, and the results show that LDH can promote the expression of Sox1, Pax6, N-cadherin and Map2 to the differentiation thereof after the addition of the early (days 1-2) and late (days 3-5) stages of NPCs differentiation.
And step two, adding MgFe-LDH materials on the 1 st day, the 3 rd day and the 5 th day of the NPCs differentiation, collecting cells of each group on the 7 th day of the differentiation, and detecting differentiation markers of the NPCs after treatment of each group by immunofluorescence staining, wherein the differentiation markers comprise Sox1, Pax6 and N-cadherin. Fixing the cells with 4% paraformaldehyde for 10min, washing with PBS for three times, permeating with 0.25% Triton X-100 (polyethylene glycol octyl phenyl ether) for 10min, then blocking with 5% goat serum for 1h to inhibit nonspecific antibody binding, incubating overnight at 4 ℃ with Sox1, Pax6 and N-cadherin primary antibody (diluted 1: 500), washing with PBS for three times, incubating at room temperature with fluorescent secondary antibody (diluted 1: 200) for 1h, washing with PBS for three times, incubating DAPI (37 ℃, 15min) for cell nucleus staining, and observing staining condition with a fluorescence confocal microscope. The antibodies used therein were all commercially available from Abcam. The results shown in FIG. 3B show that the amounts of Sox1, Pax6 and N-cadherin in NPCs after addition of the materials on day 1 were lower than those of the control group (treated without addition of the materials), that the fluorescence intensities of Pax6 and N-cadherin after addition of the materials on day 3 were higher than those of the control group, and that the protein fluorescence intensities of Pax6 and N-cadherin after addition of the materials on day 5 were the highest. This indicates that the optimal time point for MgFe-LDH nanomaterials to promote differentiation of ESCs into NPCs was day 5 of differentiation.
4. Optimal concentration screening of nano LDH material for promoting differentiation of ESCs to NPC
Step one, adding 2.5, 5, 10, 20 and 40 mu g/mL of MgFe-LDH materials respectively on the 5 th day of the differentiation process of NPCs, and detecting the differentiation efficiency of the NPCs after MgFe-LDH treatment under different concentration conditions by utilizing qPCR (figure 4A) and WB (figure 4B) on the 7 th day, wherein the qPCR results in figure 4A show that under the concentration condition of 10 mu g/mL, the expression levels of marker genes Sox1, Pax6, N-cadherin and Map2 corresponding to the NPCs are higher than that under the treatment under other concentration conditions;
step two, respectively adding 2.5, 5, 10, 20 and 40 mu g/mL MgFe-LDH materials in the NPCs differentiation process on the 5 th day, detecting the influence on the NPCs marker proteins after the MgFe-LDH materials are treated under different concentration conditions by using a protein immunoprecipitation technology (WB) on the 7 th day, quantitatively detecting the total proteins extracted from each group of cells, loading the total proteins to the sample according to the same protein amount, performing polyacrylamide gel electrophoresis, performing membrane transfer, sealing and incubation corresponding to a primary antibody and a secondary antibody on the gel after the electrophoresis is finished, exposing corresponding protein bands by using ECL luminescence liquid, and comparing the expressions of the NPCs marker proteins Sox dh 1, Pax6 and N-calcin after each group of treatment. The WB level test results in FIG. 4B also demonstrated that the protein expression levels of N-cadherin and Pax6 were higher at a concentration of 10. mu.g/mL than in the other groups under the condition of consistent expression of the internal reference protein, and the quantitative statistics in FIG. 4C also demonstrated that the optimal concentration condition of MgFe-LDH for promoting the differentiation of mESCs into NPCs was 10. mu.g/mL.
The above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, several modifications and additions can be made without departing from the method of the present invention, and these modifications and additions should also be regarded as the protection scope of the present invention.
Claims (10)
1. The application of the nano layered double hydroxide in promoting the differentiation of embryonic stem cells to neural precursor cells.
2. Use according to claim 1, characterized in that the nano-layered double hydroxide has a divalent metal cation selected from Mg2+、Zn2+And Ca2+。
3. Use according to claim 1, characterized in that the nano-layered double hydroxide has its trivalent metal cation selected from Al3+And Fe3+。
4. Use according to claim 1, characterized in that the nano-layered double hydroxide has interlayer anions selected from the group consisting of Cl-、NO3 -And SO4 2-。
5. The use according to claim 1, wherein the nano-layered double hydroxide has a molar ratio of divalent metal ions to trivalent metal ions of (0.1-5): 1.
6. Use according to claim 1, characterized in that the nano-layered double hydroxide has the general formula [ M [ ]2+ (1-x)M3 + x(OH)2]x+[An-]x/n·zH2O, wherein M2+Is a divalent metal cation, M3+Is a trivalent metal cation, An-Is an anion with the valence of n between layers, x is the molar ratio of trivalent cations to all cations, and z is the number of crystal water between each nano-layered double hydroxide molecule.
7. A method for promoting differentiation of embryonic stem cells into neural precursor cells, which comprises the step of adding a nano-layered double hydroxide into a system for differentiation of embryonic stem cells into neural precursor cells.
8. The method of claim 7, wherein the nano-layered double hydroxide is added on days 3-5 of the induced differentiation culture.
9. The method according to claim 7, wherein the concentration of the nano-layered double hydroxide in the differentiation system is 1 to 40 μ g/mL.
10. The method according to claim 9, wherein the concentration of the nano-layered double hydroxide in the differentiation system is 10 μ g/mL.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111271780.XA CN113846060B (en) | 2021-10-29 | 2021-10-29 | Application of nanomaterial in promoting differentiation of embryonic stem cells to neural precursor cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111271780.XA CN113846060B (en) | 2021-10-29 | 2021-10-29 | Application of nanomaterial in promoting differentiation of embryonic stem cells to neural precursor cells |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113846060A true CN113846060A (en) | 2021-12-28 |
CN113846060B CN113846060B (en) | 2024-04-19 |
Family
ID=78983523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111271780.XA Active CN113846060B (en) | 2021-10-29 | 2021-10-29 | Application of nanomaterial in promoting differentiation of embryonic stem cells to neural precursor cells |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113846060B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114908045A (en) * | 2022-05-16 | 2022-08-16 | 同济大学 | Application of nano layered double hydroxide/graphene quantum dot composite material in osteogenic differentiation and preparation thereof |
CN114934012A (en) * | 2022-05-16 | 2022-08-23 | 同济大学 | Application of nano layered double hydroxide in cartilage regeneration and preparation thereof |
CN115364117A (en) * | 2022-07-28 | 2022-11-22 | 同济大学 | Application of nano-layered double hydroxide in inflammatory bowel disease |
CN115364117B (en) * | 2022-07-28 | 2024-06-04 | 同济大学 | Application of nano layered double hydroxide in inflammatory bowel disease |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2510699A (en) * | 1997-12-19 | 1999-07-12 | Oliver Brustle | Neural precursor cells, method for the production and use thereof in neural defect therapy |
CN103966160A (en) * | 2014-04-11 | 2014-08-06 | 同济大学 | Application of inorganic nano-material layered double hydroxides (LDHs) in mouse embryonic stem cell culture |
CN108339151A (en) * | 2018-02-08 | 2018-07-31 | 上海市同济医院 | A kind of nano layered double hydroxides-multiple-factor combined system for promoting nerve regneration to repair spinal cord injury |
CN111808798A (en) * | 2020-09-03 | 2020-10-23 | 朗姿赛尔生物科技(广州)有限公司 | Culture medium for promoting stem cell expansion |
-
2021
- 2021-10-29 CN CN202111271780.XA patent/CN113846060B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2510699A (en) * | 1997-12-19 | 1999-07-12 | Oliver Brustle | Neural precursor cells, method for the production and use thereof in neural defect therapy |
US20080213888A1 (en) * | 1997-12-19 | 2008-09-04 | Oliver Brustle | Neural precursor cells, method for the production and use thereof in neural defect therapy |
CN103966160A (en) * | 2014-04-11 | 2014-08-06 | 同济大学 | Application of inorganic nano-material layered double hydroxides (LDHs) in mouse embryonic stem cell culture |
CN108339151A (en) * | 2018-02-08 | 2018-07-31 | 上海市同济医院 | A kind of nano layered double hydroxides-multiple-factor combined system for promoting nerve regneration to repair spinal cord injury |
CN111808798A (en) * | 2020-09-03 | 2020-10-23 | 朗姿赛尔生物科技(广州)有限公司 | Culture medium for promoting stem cell expansion |
Non-Patent Citations (2)
Title |
---|
YOUJUN WU 等: "Size-dependent effects of layered double hydroxide nanoparticles on cellular functions of mouse embryonic stem cells", NANOMEDICINE (LOND.), vol. 10, no. 23, 26 November 2015 (2015-11-26), pages 3469 * |
孟凡刚 等: "胚胎干细胞向神经细胞分化及其在神经科学领域中的应用现状及前景", 国外医学神经病学神经外科学分册, vol. 31, no. 2, 30 April 2004 (2004-04-30), pages 190 - 193 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114908045A (en) * | 2022-05-16 | 2022-08-16 | 同济大学 | Application of nano layered double hydroxide/graphene quantum dot composite material in osteogenic differentiation and preparation thereof |
CN114934012A (en) * | 2022-05-16 | 2022-08-23 | 同济大学 | Application of nano layered double hydroxide in cartilage regeneration and preparation thereof |
CN114934012B (en) * | 2022-05-16 | 2023-11-10 | 同济大学 | Application of nano layered double hydroxide in cartilage regeneration and preparation thereof |
WO2023221988A1 (en) * | 2022-05-16 | 2023-11-23 | 同济大学 | Use of nano layered double hydroxides in cartilage regeneration and method for preparing same |
CN115364117A (en) * | 2022-07-28 | 2022-11-22 | 同济大学 | Application of nano-layered double hydroxide in inflammatory bowel disease |
CN115364117B (en) * | 2022-07-28 | 2024-06-04 | 同济大学 | Application of nano layered double hydroxide in inflammatory bowel disease |
Also Published As
Publication number | Publication date |
---|---|
CN113846060B (en) | 2024-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6257520B2 (en) | Automated system for generating induced pluripotent stem cells or differentiated cells | |
CN113846060A (en) | Application of nano material in promoting differentiation of embryonic stem cells to neural precursor cells | |
Dai et al. | Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach | |
CN106399231B (en) | Application of nano graphene oxide in promoting culture and self-renewal of mouse embryonic stem cells | |
JP6889107B2 (en) | Nervous system cells expressing adenovirus E4ORF1, and methods for producing and using them. | |
CN108504625B (en) | Mouse fibroblast and application thereof | |
CN106350521B (en) | A kind of preparation method of the patient-specific motor neuron of ALS | |
WO2018143312A1 (en) | Differentiation control method for pluripotent stem cells | |
Wang et al. | The neural stem cell properties of PKD2L1+ cerebrospinal fluid-contacting neurons in vitro | |
CN111254108B (en) | Silk protein hydrogel and preparation method and application thereof | |
CN114207111A (en) | Method for preparing skin-derived pluripotent precursor cells | |
Tang et al. | The combination of dextran sulphate and polyvinyl alcohol prevents excess aggregation and promotes proliferation of pluripotent stem cells in suspension culture | |
CN114657184B (en) | Multivalent aptamer functionalized DNA nanostructure probe and preparation method and application thereof | |
WO2019163802A1 (en) | Method for evaluating embryoid body | |
CN107964533B (en) | Molybdenum disulfide used for stem cell proliferation and/or differentiation and substrate for stem cell proliferation and/or differentiation, preparation method and application | |
WO2022188395A1 (en) | Method for culturing pluripotent stem cells | |
CN111592585A (en) | Application of UL16 protein in preparation of drugs for promoting cell mitochondrial function | |
CN113801843B (en) | Method for enhancing human urine-derived stem cell stem property | |
EP2845899B1 (en) | Method for preparing dopaminergic neuron-like cell cluster | |
JP2010004796A (en) | Differentiation inhibitor, differentiation inhibitory base material, and differentiation inhibiting method and use of the method | |
Jasty et al. | Profiling of DNA and histone methylation reveals epigenetic-based regulation of gene expression during retinal differentiation of stem/progenitor cells isolated from the ciliary pigment epithelium of human cadaveric eyes | |
CN115885037A (en) | Midbrain organoid, high-speed large-scale production method thereof, method for screening neurotoxic substance and method for screening dopaminergic neuron-related disease drug using the same | |
WO2019225672A1 (en) | Method for inducing conjunctival cells derived from pluripotent stem cells | |
CN111643522B (en) | Application of nano-hydroxyapatite in preparation of drugs for preventing or treating basal cell carcinoma | |
KR20190130394A (en) | A composition for stimulating differentiation of stem cell comprising multi-layer graphene film and culture broth of progenitor cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |